| Literature DB >> 34150948 |
Atefeh Tavangar1, Faezeh Khozeimeh1, Mehdi Razzaghi-Abyaneh2, Safieh Sherkat3.
Abstract
STATEMENT OF THE PROBLEM: Various species of candida contribute to oral candidiasis. It is the time to shift from conventional rigid antimicrobial therapies to more patient specific and safer ones.Entities:
Keywords: Candida; Indocyanine green; Laser; Nystatin; Photodynamic therapy; Photosensitizer
Year: 2021 PMID: 34150948 PMCID: PMC8206599 DOI: 10.30476/DENTJODS.2020.81817.0
Source DB: PubMed Journal: J Dent (Shiraz) ISSN: 2345-6418
Laser parameters and specifications
| Parameter | Amount |
|---|---|
| Laser power | 100 mW |
| WRadiation duration | 100 sec |
| Dose | 10 J/cm2 |
| wavelength | 808 nm |
| Probe status | No contact |
| Radiation mode | Continuous |
| Probecross section diameter | 1 cm |
| Model | Polaris 2/SW PM2-25/M1/AP ver 4/0, (Star company, Bielsko-Biata, Poland) |
Figure 1Colony count set
The number of candida colonies according to candida type methods treatment
| Interval of 95 percent reliability for average | |||||||
|---|---|---|---|---|---|---|---|
| Candida strain | Group | Average | Standard deviation | Down limit | Up Limit | Minimum | Maximum |
| Control | 1064.80 | 133.042 | 969.63 | 1159.97 | 910 | 1300 | |
| PS | 877.40 | 146.973 | 772.26 | 982.54 | 620 | 1094 | |
| PDT | 719.80 | 96.957 | 650.44 | 789.16 | 600 | 880 | |
| Laser | 614.60 | 89.399 | 555.66 | 673.54 | 530 | 730 | |
| Nystatin | 43.70 | 11.738 | 35.30 | 52.10 | 25 | 64 | |
| Control | 925.30 | 74.005 | 872.36 | 978.24 | 829 | 1042 | |
| PS | 810.90 | 46.615 | 777.55 | 844.25 | 722 | 864 | |
| PDT | 706.50 | 49.718 | 670.93 | 742.07 | 640 | 780 | |
| Laser | 505.50 | 73.686 | 452.79 | 558.21 | 410 | 620 | |
| Nystatin | 85.00 | 19.872 | 70.78 | 99.22 | 48 | 116 | |
| Control | 1279.40 | 98.067 | 1209.25 | 1349.55 | 1100 | 1432 | |
| PS | 922.50 | 70.352 | 872.17 | 972.83 | 800 | 1000 | |
| PDT | 742.10 | 102.499 | 677.78 | 814.42 | 600 | 949 | |
| Laser | 533.60 | 87.297 | 471.15 | 596.05 | 414 | 657 | |
| Nystatin | 218.40 | 35.211 | 193.21 | 243.59 | 176 | 276 | |
| Control | 1100.20 | 137.056 | 1002.16 | 1198.24 | 900 | 1300 | |
| PS | 846.40 | 105.833 | 770.69 | 922.11 | 730 | 1000 | |
| PDT | 675.30 | 104.368 | 600.64 | 749.96 | 514 | 810 | |
| Laser | 659.40 | 62.717 | 614.54 | 704.26 | 575 | 749 | |
| Nystatin | 0 | 0 | 0 | 0 | 0 | 0 | |
The results of dual comparison of the study groups for each candida by "p Value"
| Candida type | Comparison Group | |
|---|---|---|
| 0.088 | Control- PS | |
| 0.0 | Control- PDT | |
| 0.0 | Control- Laser | |
| 0.0 | Control- Nystatin | |
| 0.130 | PDT- PS | |
| 0.001 | Laser-PS | |
| 0.0 | Nystatin-PS | |
| 0.151 | PDT- Laser | |
| 0.0 | PDT- Nystatin | |
| 0.0 | Nystatin- Laser | |
| 0.006 | Control- PS | |
| 0.0 | Control- PDT | |
| 0.0 | Control- Laser | |
| 0.0 | Control- Nystatin | |
| 0.002 | PDT- PS | |
| 0.0 | Laser-PS | |
| 0.0 | Nystatin-PS | |
| 0.0 | PDT- Laser | |
| 0.0 | PDT- Nystatin | |
| 0.0 | Nystatin- Laser | |
| 0.0 | Control- PS | |
| 0.0 | Control- PDT | |
| 0.0 | Control- Laser | |
| 0.0 | Control- Nystatin | |
| 0.004 | PDT- PS | |
| 0.0 | Laser-PS | |
| 0.0 | Nystatin-PS | |
| 0.0 | PDT- Laser | |
| 0.0 | PDT- Nystatin | |
| 0.0 | Nystatin- Laser | |
| 0.001 | Control- PS | |
| 0.012 | Control- PDT | |
| 0.001 | Control- Laser | |
| 0.0 | PS- PDT | |
| 0.0 | PS- Laser | |
| 1.000 | PDT- Laser |